• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

滤泡树突状细胞诱导的 microRNA 介导的非霍奇金 B 细胞淋巴瘤中 PRDM1 的上调和 BCL-6 的下调。

Follicular dendritic cell-induced microRNA-mediated upregulation of PRDM1 and downregulation of BCL-6 in non-Hodgkin's B-cell lymphomas.

机构信息

Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, University of South Florida, Tampa, FL 33613, USA.

出版信息

Leukemia. 2011 Jan;25(1):145-52. doi: 10.1038/leu.2010.230. Epub 2010 Oct 22.

DOI:10.1038/leu.2010.230
PMID:20966935
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3083119/
Abstract

B-cell lymphoma 6 (BCL6) and PR domain containing 1 (PRDM1) are considered as master regulators for germinal center (GC) formation and terminal B-cell differentiation. Dysregulation of BCL6 and PRDM1 has been associated with lymphomagenesis. Here, we show for the first time that direct cell-cell contact between follicular dendritic cells (FDC) and B-lymphocytes, by influencing the expression of a set of microRNAs (miRNAs), regulates the expression of BCL6 and PRDM1. We identify that, on cell adhesion to FDC, FDC induces upregulation of PRDM1 expression through downregulation of miR-9 and let-7 families and induces downregulation of BCL-6 through upregulation of miR-30 family in B-lymphocytes and lymphoma cells. We further demonstrate that the miR-30 family directly controls BCL-6 expression and miR-9-1 and let-7a directly control PRDM-1 expression through targeting their 3'UTR, mediating the FDC effect. Our studies define a novel regulatory mechanism in which the FDC, through induction of miRNAs in B-lymphocytes, orchestrates the regulation of transcription factors, promotes germinal center B-cell survival and differentiation. Dysregulation of miRNAs may interfere with B-cell survival and maturation, thus representing a novel molecular mechanism, as well as a potential therapeutic target in B-cell lymphomas.

摘要

B 细胞淋巴瘤 6(BCL6)和 PR 结构域包含 1(PRDM1)被认为是生发中心(GC)形成和终末 B 细胞分化的主要调节因子。BCL6 和 PRDM1 的失调与淋巴瘤的发生有关。在这里,我们首次表明,滤泡树突状细胞(FDC)与 B 淋巴细胞之间的直接细胞-细胞接触通过影响一组 microRNAs(miRNAs)的表达来调节 BCL6 和 PRDM1 的表达。我们发现,在细胞黏附到 FDC 上时,FDC 通过下调 miR-9 和 let-7 家族来诱导 PRDM1 表达上调,并通过上调 miR-30 家族在 B 淋巴细胞和淋巴瘤细胞中诱导 BCL-6 下调。我们进一步证明,miR-30 家族通过靶向其 3'UTR 直接控制 BCL-6 的表达,miR-9-1 和 let-7a 通过靶向其 3'UTR 直接控制 PRDM-1 的表达,介导 FDC 的作用。我们的研究定义了一种新的调节机制,其中 FDC 通过诱导 B 淋巴细胞中的 miRNAs,协调转录因子的调节,促进生发中心 B 细胞的存活和分化。miRNAs 的失调可能会干扰 B 细胞的存活和成熟,因此代表了一种新的分子机制,以及 B 细胞淋巴瘤的潜在治疗靶点。

相似文献

1
Follicular dendritic cell-induced microRNA-mediated upregulation of PRDM1 and downregulation of BCL-6 in non-Hodgkin's B-cell lymphomas.滤泡树突状细胞诱导的 microRNA 介导的非霍奇金 B 细胞淋巴瘤中 PRDM1 的上调和 BCL-6 的下调。
Leukemia. 2011 Jan;25(1):145-52. doi: 10.1038/leu.2010.230. Epub 2010 Oct 22.
2
MicroRNA-mediated down-regulation of PRDM1/Blimp-1 in Hodgkin/Reed-Sternberg cells: a potential pathogenetic lesion in Hodgkin lymphomas.微小RNA介导霍奇金/里德-斯腾伯格细胞中PRDM1/Blimp-1的下调:霍奇金淋巴瘤中一种潜在的致病损伤
Am J Pathol. 2008 Jul;173(1):242-52. doi: 10.2353/ajpath.2008.080009.
3
BCL6 programs lymphoma cells for survival and differentiation through distinct biochemical mechanisms.BCL6通过不同的生化机制使淋巴瘤细胞得以存活和分化。
Blood. 2007 Sep 15;110(6):2067-74. doi: 10.1182/blood-2007-01-069575. Epub 2007 Jun 1.
4
PRDM1/Blimp1 downregulates expression of germinal center genes LMO2 and HGAL.PRDM1/Blimp1 下调生发中心基因 LMO2 和 HGAL 的表达。
FEBS J. 2011 Sep;278(17):3065-75. doi: 10.1111/j.1742-4658.2011.08227.x. Epub 2011 Aug 2.
5
Follicular dendritic cell-dependent drug resistance of non-Hodgkin lymphoma involves cell adhesion-mediated Bim down-regulation through induction of microRNA-181a.滤泡树突状细胞依赖性非霍奇金淋巴瘤的耐药性涉及细胞黏附介导的 Bim 下调,其通过诱导 microRNA-181a 实现。
Blood. 2010 Dec 9;116(24):5228-36. doi: 10.1182/blood-2010-03-275925. Epub 2010 Sep 14.
6
IRF4 negatively regulates proliferation of germinal center B cell-derived Burkitt's lymphoma cell lines and induces differentiation toward plasma cells.IRF4负向调控生发中心B细胞来源的伯基特淋巴瘤细胞系的增殖,并诱导其向浆细胞分化。
Eur J Cell Biol. 2007 Oct;86(10):581-9. doi: 10.1016/j.ejcb.2007.05.006. Epub 2007 Jul 24.
7
Epigenetic down-regulation of the tumor suppressor gene PRDM1/Blimp-1 in diffuse large B cell lymphomas: a potential role of the microRNA let-7.抑癌基因 PRDM1/Blimp-1 在弥漫性大 B 细胞淋巴瘤中的表观遗传学下调:微小 RNA let-7 的潜在作用。
Am J Pathol. 2010 Sep;177(3):1470-9. doi: 10.2353/ajpath.2010.091291. Epub 2010 Jul 22.
8
EBV-miR-BHRF1-2 targets PRDM1/Blimp1: potential role in EBV lymphomagenesis.EBV-微小RNA-BHRF1-2靶向PRDM1/Blimp1:在EBV淋巴瘤发生中的潜在作用
Leukemia. 2016 Mar;30(3):594-604. doi: 10.1038/leu.2015.285. Epub 2015 Nov 4.
9
The downregulation of PRDM1/Blimp-1 is associated with aberrant expression of miR-223 in extranodal NK/T-cell lymphoma, nasal type.PRDM1/Blimp-1的下调与鼻型结外NK/T细胞淋巴瘤中miR-223的异常表达相关。
J Exp Clin Cancer Res. 2014 Jan 17;33(1):7. doi: 10.1186/1756-9966-33-7.
10
CD99 triggers upregulation of miR-9-modulated PRDM1/BLIMP1 in Hodgkin/Reed-Sternberg cells and induces redifferentiation.CD99 触发 Hodgkin/Reed-Sternberg 细胞中 miR-9 调节的 PRDM1/BLIMP1 的上调,并诱导再分化。
Int J Cancer. 2012 Aug 15;131(4):E382-94. doi: 10.1002/ijc.26503. Epub 2011 Dec 2.

引用本文的文献

1
MicroRNA Expression Profile in Bone Marrow and Lymph Nodes in B-Cell Lymphomas.骨髓和淋巴结中 B 细胞淋巴瘤的 microRNA 表达谱。
Int J Mol Sci. 2023 Oct 11;24(20):15082. doi: 10.3390/ijms242015082.
2
MicroRNA-regulated B cells in obesity.肥胖中受微小RNA调控的B细胞。
Immunometabolism (Cobham). 2022 Aug 5;4(3):e00005. doi: 10.1097/IN9.0000000000000005. eCollection 2022 Jul.
3
Non-Coding RNAs in Normal B-Cell Development and in Mantle Cell Lymphoma: From Molecular Mechanism to Biomarker and Therapeutic Agent Potential.非编码 RNA 在正常 B 细胞发育和套细胞淋巴瘤中的作用:从分子机制到生物标志物和治疗剂潜力。
Int J Mol Sci. 2021 Aug 31;22(17):9490. doi: 10.3390/ijms22179490.
4
CAM-DR: Mechanisms, Roles and Clinical Application in Tumors.CAM-DR:肿瘤中的机制、作用及临床应用
Front Cell Dev Biol. 2021 Jul 6;9:698047. doi: 10.3389/fcell.2021.698047. eCollection 2021.
5
miRNA-Mediated Control of B Cell Responses in Immunity and SLE.miRNA 介导的对免疫和系统性红斑狼疮中 B 细胞反应的调控。
Front Immunol. 2021 May 17;12:683710. doi: 10.3389/fimmu.2021.683710. eCollection 2021.
6
The Multifaceted Role and Utility of MicroRNAs in Indolent B-Cell Non-Hodgkin Lymphomas.微小RNA在惰性B细胞非霍奇金淋巴瘤中的多方面作用及应用
Biomedicines. 2021 Mar 25;9(4):333. doi: 10.3390/biomedicines9040333.
7
The receptor of the colony-stimulating factor-1 (CSF-1R) is a novel prognostic factor and therapeutic target in follicular lymphoma.集落刺激因子-1(CSF-1R)受体是滤泡性淋巴瘤的一个新的预后因素和治疗靶点。
Leukemia. 2021 Sep;35(9):2635-2649. doi: 10.1038/s41375-021-01201-9. Epub 2021 Mar 17.
8
Identification BCL6 and miR-30 family associating with Ibrutinib resistance in activated B-cell-like diffuse large B-cell lymphoma.鉴定 BCL6 和 miR-30 家族与激活 B 细胞样弥漫性大 B 细胞淋巴瘤伊布替尼耐药相关。
Med Oncol. 2021 Feb 25;38(4):33. doi: 10.1007/s12032-021-01470-5.
9
The Role of Noncoding RNAs in B-Cell Lymphoma.非编码RNA在B细胞淋巴瘤中的作用。
Front Oncol. 2020 Oct 23;10:577890. doi: 10.3389/fonc.2020.577890. eCollection 2020.
10
The Interplay between MicroRNAs and the Components of the Tumor Microenvironment in B-Cell Malignancies.微小 RNA 与 B 细胞恶性肿瘤肿瘤微环境成分之间的相互作用。
Int J Mol Sci. 2020 May 11;21(9):3387. doi: 10.3390/ijms21093387.

本文引用的文献

1
Src homology 2 domain-containing inositol-5-phosphatase and CCAAT enhancer-binding protein beta are targeted by miR-155 in B cells of Emicro-MiR-155 transgenic mice.在Emicro-MiR-155转基因小鼠的B细胞中,含Src同源2结构域的肌醇-5-磷酸酶和CCAAT增强子结合蛋白β是miR-155的作用靶点。
Blood. 2009 Aug 13;114(7):1374-82. doi: 10.1182/blood-2009-05-220814. Epub 2009 Jun 11.
2
Identification of the human mature B cell miRNome.人类成熟B细胞微小RNA组的鉴定。
Immunity. 2009 May;30(5):744-52. doi: 10.1016/j.immuni.2009.03.017. Epub 2009 May 14.
3
miRNA profiling of B-cell subsets: specific miRNA profile for germinal center B cells with variation between centroblasts and centrocytes.B细胞亚群的微小RNA分析:生发中心B细胞的特异性微小RNA谱,其中中心母细胞和中心细胞之间存在差异。
Lab Invest. 2009 Jun;89(6):708-16. doi: 10.1038/labinvest.2009.26. Epub 2009 Apr 6.
4
MiRNAs and cancer.微小RNA与癌症。
Am J Pathol. 2009 Apr;174(4):1131-8. doi: 10.2353/ajpath.2009.080794. Epub 2009 Mar 5.
5
Patterns of microRNA expression characterize stages of human B-cell differentiation.微小RNA表达模式表征人类B细胞分化阶段。
Blood. 2009 May 7;113(19):4586-94. doi: 10.1182/blood-2008-09-178186. Epub 2009 Feb 6.
6
MicroRNAs in the ontogeny of leukemias and lymphomas.白血病和淋巴瘤发生过程中的微小RNA
Leuk Lymphoma. 2009 Feb;50(2):160-70. doi: 10.1080/10428190802535114.
7
Differentiation stage-specific expression of microRNAs in B lymphocytes and diffuse large B-cell lymphomas.微小RNA在B淋巴细胞和弥漫性大B细胞淋巴瘤中的分化阶段特异性表达。
Blood. 2009 Apr 16;113(16):3754-64. doi: 10.1182/blood-2008-10-184077. Epub 2008 Dec 1.
8
MicroRNA-mediated down-regulation of PRDM1/Blimp-1 in Hodgkin/Reed-Sternberg cells: a potential pathogenetic lesion in Hodgkin lymphomas.微小RNA介导霍奇金/里德-斯腾伯格细胞中PRDM1/Blimp-1的下调:霍奇金淋巴瘤中一种潜在的致病损伤
Am J Pathol. 2008 Jul;173(1):242-52. doi: 10.2353/ajpath.2008.080009.
9
MicroRNAs and lymphomas.微小RNA与淋巴瘤
Ann Oncol. 2008 Jun;19 Suppl 4:iv39-40. doi: 10.1093/annonc/mdn192.
10
MicroRNA-155 is a negative regulator of activation-induced cytidine deaminase.微小RNA-155是活化诱导胞苷脱氨酶的负调节因子。
Immunity. 2008 May;28(5):621-9. doi: 10.1016/j.immuni.2008.03.015. Epub 2008 May 1.